20 results
8-K
ATOS
Atossa Therapeutics Inc
1 Jul 22
Regulation FD Disclosure
9:01am
or that the Neoadjuvant Study will commence.
Atossa continues to recruit participants for its ongoing Phase 2 clinical study of (Z)-endoxifen in premenopausal women
424B3
8xx0z19imu0o
19 Apr 13
Prospectus supplement
12:00am
DEF 14A
z3gy7y 4f9mdz95d
15 Apr 13
Definitive proxy
12:00am
10-K
snbp5
28 Mar 13
Annual report
12:00am
- Prev
- 1
- Next